Monthly chemistry ortho clinical diagnostics testing for medical treatment facility

Ended Awarded Last action

Contract number
HT009026FG0140004
Awardee
Awarding agency
Obligated
$34,467

Award facts

Contract value 100% obligated
$34,466.50 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
5680 Miscellaneous Construction Materials
Set-aside
No set-aside
Competition
Competed under SAP · 2 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Raritan, NJ 08869, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency awarded a firm fixed-price Blanket Purchase Agreement call to Ortho-Clinical Diagnostics, Inc. on January 27, 2026, for monthly chemistry testing services at a medical treatment facility. The contract, valued at $34,466.50 with a completion date of September 30, 2026, represents a delivery order against an existing blanket purchase agreement vehicle and involves routine clinical laboratory diagnostic services utilizing Ortho-Clinical's VITROS chemistry analyzer systems and associated reagents. The award was made through open competition with no set-aside designation, reflecting the contractor's established competitive position in federal healthcare diagnostics procurement.

Ortho-Clinical Diagnostics, Inc., headquartered in Raritan, New Jersey, is a specialized medical equipment manufacturer with extensive federal healthcare market experience across multiple agencies including the Department of Veterans Affairs, Indian Health Service, and National Institutes of Health. The company's established blanket purchase agreement and indefinite delivery contract vehicles, including a high-value $1.6M IDC through the Department of Veterans Affairs and GSA Schedule contracts, demonstrate its critical role as a supplier of laboratory testing infrastructure and diagnostic consumables to the federal healthcare system. This award supports ongoing clinical chemistry testing requirements for Defense Health Agency medical facilities.

Quick answers

Who was awarded contract HT009026FG0140004?

HT009026FG0140004 was awarded to Ortho-Clinical Diagnostics, Inc. by Defense Health Agency (Department of Defense) on January 27, 2026.

How much is contract HT009026FG0140004 worth?

The government has obligated $34,467 on HT009026FG0140004.

Is contract HT009026FG0140004 an order under another contract?

Yes. HT009026FG0140004 is a BPA call under FA860122A0002, a blanket purchase agreement.

Was contract HT009026FG0140004 competed?

The extent of competition for HT009026FG0140004 was competed under sap. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award